Comparative analysis of specific and non-specific markers in patients with different stages of liver fibrosis in chronic hepatitis C
- Авторлар: Nikolaeva L.I.1, Shevchenko N.G.1,2, Dedova A.V.1, Sapronov G.V.1,2, Samokhvalov E.I.1, Vakhromeev A.A.1
-
Мекемелер:
- Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia
- Russian Medical Academy of Continuing Professional Education, Ministry of Health
- Шығарылым: Том 12, № 4 (2022)
- Беттер: 61-67
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287994
- DOI: https://doi.org/10.18565/epidem.2022.12.4.61-7
- ID: 287994
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Lyudmila Nikolaeva
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia
Email: l.i.nikolaeva@mail.ru
BD, leading researcher of laboratory of gene engineering products
Nadezhda Shevchenko
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; Russian Medical Academy of Continuing Professional Education, Ministry of Health
Email: dr.nadya@inbox.ru
junior researcher of laboratory of gene engineering products
Anna Dedova
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia
Email: dedova.anna2010@mail.ru
research assistant of laboratory of gene engineering products
Georgiy Sapronov
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; Russian Medical Academy of Continuing Professional Education, Ministry of Health
Email: g_sapronov@mail.ru
PhD in medicine, senior researcher of laboratory of gene engineering products
Evgeniy Samokhvalov
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia
Email: e-samokh@hotmail.com
PhD in biology, leading researcher of laboratory ofviral ecology
Artemiy Vakhromeev
Honorary Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia
Email: bioartemiyvakhrameev@gmail.com
junior researcher of laboratory of gene engineering products
Әдебиет тізімі
- Daw M.A., El-Bouzedi A.A., Ahmed M.O., Dau A.A., Agnan M.M., Drah A.M. Geographic integration of hepatitis C. virus: A global threat. World J. Virol. 2016; 5(4): 170-82. https://doi.org/10.5501/wjv.v5.i4.170
- Petruzziello A., Marigliano S., Loquercio G., Cozzolono A., Cacciapuoti C. Global epidemiology of hepatitis C. virus infection: An up-date of the distribution and circulation of hepatitis C. virus genotypes. World J. Gastroenterol. 2016; 22(34): 7824-40. https://doi.org/10.3748/wjg.v22.i34.7824
- Чуланов В.П., Пименов Н.Н., Мамонов Н.А., Сагалова О.И., Шестакова И.В., Покровский В.И. Хронический гепатит С. как проблема здравоохранения России сегодня и завтра. Терапевтический архив 2015; (11): 5-10.
- О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2014 году: Государственный доклад. М., 2015. http://rospotrebnadzor.ru/upload/iblock/22c/gd_2014_seb_dlya-sayta.pdf.
- Инфекционная заболеваемость в Российской Федерации за январь-декабрь 2021 г. http://www.rospotrebnadzor.ru
- Falada-Nwulia O., Suares-Cuervo C., Nelson D.R., Fried M.W., Segal J.B., Sulkowski M.S. Oral direct-acting agent therapy for hepatitis C. virus infection: a systematic review. Ann Intern Med. 2017; 166: 637-48. https://doi.org/10.7326/M16-2575
- Rosecrans A.M., Cheedalla A., Rives S.T., Scotti L.A., Harris R.E., Greenbaum A.H. et al. Public health clinic-based hepatitis C. treatment. Am. J. Prev. Med. 2020; 59: 420-7. https://doi.org/10.1016/j.amepre.2020.03.006
- World Health Organization. Global hepatitis report. Geneva, Swizerland: WHO, 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
- Bartenschlager R., Baumert T.F., Bukh J., Lemon M., Lindenbach S., Lohmann B. et al. Critical сhallenges and emerging opportunities in hepatitis C research in an era of potent antiviral therapy: considerations for scientists and funding agencies. Virus Res. 2018; 248: 53-62. https://doi.org/10.1016/j.virusres.2018.02.016
- Roche B., Coilly A., Duclos-Vallec J.C., Sammuel D. The impact of treatment of hepatitis C. with DA As on occurrence of HCC. Liver Int. 2018; 38(Suppl.1): 139-45. https://doi.org/10.1111/liv.13659
- Guarino M., Sessa A., Cossiga V., Special interest group on «Hepatocellular carcinoma and new anti-HCV therapies» of the Italian Association for the Study of the Liver. Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: a few lights and many shadows. World J. Gastroenterol. 2018; 24: 2582-95. https://doi.org/10.3748/wjg.v24.2582
- Patel K., Friedrich-Rust M., Lurie Y., Grigorescu M., Stanclu C., Lee C.M. et al. FibroSURE and FibroScan in treatment response in chronic hepatitis C. virus. World J. Gastroenterol. 2011; 17(41): 4581-9. https://doi.org/10.3748/wjg.v17.i41.4581
- Bedossa P., Carrat F. Liver biopsy: the best, not the gold standard. J. Hepatol. 2009; 50(1): 1-3. https://doi.org/10.1016/jhep.2008.10.014
- Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O’Huigin C. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C. virus. Nature 2009; 461(7265): 798- 801. https://doi.org/10.1038/nature08463
- Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T. et al. Genetic variation in IL28B is associated with chronic hepatitis C. and treatment failure: A Genome-Wide Association Study. Gastroenterology 2010; 38(4): 1338-45. https://doi.org/10.1053/j.gastro.2009.12/056
- Muir A.J. IL28B in the era of direct-acting antivirals for hepatitis C. J. Clin. Gastroenterol. 2013; 47(3): 222-7. https://doi.org/10.1097/MCG.0b013e3182680221
- Eslam M., Hashem A.M., Leung R., Romero-Gomez M., Berg T., Dore G.J. et al. Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat. Commun. 2015; (6): 6422. doi: 10.1038/ncomms7422
- Al-Qahtani A., Al-Anazi M., Abdo A.A., Sanai F.M., Al-Hamoudi W., Alswat K.A. et al. Correlation between genetic variations and serum level of interleukin 28B with genotypes and disease progression in chronic hepatitis C. virus infection. J. Immunol. Res. 2015; (1): 768470. https://doi.org/10.1155/2015/768470
- Ohno T., Mizokami M., Wu N., Saleh M.G., Ohba K.-I., Orito E. et al. New hepatitis C. virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 3a, 3b,4, 5a, and 6a. J. Clin. Microbiol. 1997; 35(1): 201-7. https://doi.org/10.1128/jcm.35.1.201-207
- Sanger F., Niclein S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 1977; 74: 5463-7. https://doi.org/10.1073/pnas.74.12.5463
- Nikolaeva L.I., Blokhina N.P., Tsurikova N.N., Voronkova N.V., Miminoshvili M.I., Braginsky D.M. et al. Virus-specific antibody titres in different phases of hepatitis C. virus infection. J. Viral. Hepatol. 2002; (9): 429-37. https://doi.org/10.1046/j.1365-2893.2002.00369.x
- Bortolotii F., Verucchi G., Camma C., Cabibbo G., Zancan L., Indolfi G. et al. Long-term course of chronic hepatitis C. in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134(7): 1900-7. https://doi.org/10.1053/j.gastro.2008.02.082
- Roffi L., Redaelli A., Colloredo G., Minola E., Donada C., Picciotto A. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis c: influence of HCV genotype. Eur. J. Gastroenterol. Hepatol. 2001; 13(5): 501-6.
- Bochud P.-Y., Cat T., Overbeck K., Bochud M., Dufour J.F., Mullhaupt B. et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J. Hepatol. 2009; 51(4): 655-66. https://doi.org/10.1016/j.hep.2009.05.016
- Wu N., Rao H.-Y., Yang W.-B., Gao Z.-L., Yang R.-F., Fei R. et al. Impact of hepatitis C. virus genotype 3 on liver diease progression in a Chinese national cohort. Chin. Med. J. (Engl.). 2020; 133(3): 253-61. https://doi.org/10.1097/CM9.0000000000000629
- Самохвалов Е.И., Николаева Л.И., Альховский С.В., Хлопова И.Н., Макашова В.В., Петрова Е.В. и др. Частота встречаемости отдельных субтипов вируса гепатита С. в Московском регионе. Вопр. вирусол. 2013; 58(1): 36-40.
- Mukomolov S., Trifonova G., Levakova I., Bolsun D., Krivanogova E. Hepatitis C. in the Russian Federation: challenges and future directions. Hepat. Med. 2016; (8): 51-60. https://doi.org/10.2147/HMER.S50172
- Жданов К.В., Гусев Д.А., Козлов К.В., Сукачев В.С., Шекуров А.В., Жабров С.С. и др. Взаимосвязь полиморфизмов гена ИЛ-28В, клинико-лабораторных и вирусологических показателей при хронической HCV-инфекции. Журн. инфектол. 2014; 6(4): 19-26.
- Tamaki N., Kurosaki M., Higuchi M., Takada H., Nakakuki N., Yasui Y. et al. Genetic polymorphisms of IL28B and PNPLA3 are predictive for HCV related rapid fibrosis progression and identify patients who require urgent antiviral treatment with new regimens. PLOS Оne 2015; 10(9): e0137351. https://doi.org/10.1371/journal.pone.0137351
- Zai M., Long J., Liu S., Liu C., Li L., Yang L., Li Y., Shu B. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY) 2021; 13(1): 279-300. https://doi.org/10.18632/aging.104127